CaeliVascular is a medical device developer and manufacturer organized around creating solutions for venous clots. Based in St. Louis, MO and having strong ties to Washington University in that state, CaeliVascular has developed the Hydra Catheter to treat Venous Thrombosis and Pulmonary Embolism. Tackling the transforming of treatment for deep vein thrombosis and pulmonary embolism, Caeli Vascular is developing and commercializing breakthrough minimally invasive therapies for the treatment of venous thromboembolism (VTE).
